Pen needle use patterns in an insured population with diabetes: U.S. retrospective claims analysis

IF 2.5 4区 医学 Q3 PHARMACOLOGY & PHARMACY
Laura Lupton, Xiaowu Sun, Pasha Javadi, Jennifer D. Goldman, Susan Cornell, Joaquim Fernandes, Sudha Kishorekumar, Andrew Thach, Ray Sieradzan
{"title":"Pen needle use patterns in an insured population with diabetes: U.S. retrospective claims analysis","authors":"Laura Lupton,&nbsp;Xiaowu Sun,&nbsp;Pasha Javadi,&nbsp;Jennifer D. Goldman,&nbsp;Susan Cornell,&nbsp;Joaquim Fernandes,&nbsp;Sudha Kishorekumar,&nbsp;Andrew Thach,&nbsp;Ray Sieradzan","doi":"10.1016/j.japh.2024.102124","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>People with diabetes who inject insulin with pen devices may reuse the pen needles (PNs), a practice that can cause PN tip deformity, breakage, and contamination, and that is associated with lipohypertrophy and injection-related pain.</p></div><div><h3>Objective</h3><p>This retrospective study aimed to estimate the extent of PN reuse among people with diabetes in 2 insured populations in the United States.</p></div><div><h3>Methods</h3><p>Using claims data for Commercial Fully Insured (CFI) and Medicare Advantage (MA) populations from 1-Oct-2018 to 31-Dec-2022, we identified adults with type 1 or type 2 diabetes (T1D/T2D) who had ≥ 1 claim for PNs and ≥ 2 claims for insulin from 1-Jan-2019 to 31-Dec-2021, with continuous medical/pharmacy eligibility for 3 months before first claim and 1 year after (follow-up). Those receiving hospice or palliative care or using mail order prescriptions were excluded. We compared actual annual fill rate of PNs with expected fill rate (assuming single use) according to prescribed insulin regimen. Whether the annual actual-to-expected ratio for PN numbers equaled 1 was evaluated using sign tests with 2-sided <em>P</em> values.</p></div><div><h3>Results</h3><p>Median annual actual-to-expected ratios ranged from 0.41 (T1D basal+prandial cohort) to 0.82 (T2D basal cohort; all <em>P</em> &lt; 0.001) in the CFI population (N = 10,854), and from 0.55 (TID basal + prandial) to 1.10 (T2D basal and basal + prandial; <em>P</em> = 0.382-&lt; 0.001) in the MA population (N = 32,495); medians were 0.34 and 0.55 for 4 expected T2D basal + prandial injections/day in CFI and MA populations, respectively (<em>P</em> &lt; 0.001). Annual actual-to-expected ratios were &lt; 1 for 62% and 47% of CFI and MA populations, respectively. An estimated 2%-27% and 0%-17%, respectively, depending on insulin regimen, had inadequate supplies of PNs suggesting that PNs could have been used ≥ 5 times.</p></div><div><h3>Conclusion</h3><p>These findings highlight the need for educating people with diabetes about reasons for avoiding PN reuse and the key role that pharmacists can play in providing this information and adequate supplies of PNs.</p></div>","PeriodicalId":50015,"journal":{"name":"Journal of the American Pharmacists Association","volume":null,"pages":null},"PeriodicalIF":2.5000,"publicationDate":"2024-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1544319124001444/pdfft?md5=cdada9b6004302e9f1da9a4695c6da44&pid=1-s2.0-S1544319124001444-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the American Pharmacists Association","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1544319124001444","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

People with diabetes who inject insulin with pen devices may reuse the pen needles (PNs), a practice that can cause PN tip deformity, breakage, and contamination, and that is associated with lipohypertrophy and injection-related pain.

Objective

This retrospective study aimed to estimate the extent of PN reuse among people with diabetes in 2 insured populations in the United States.

Methods

Using claims data for Commercial Fully Insured (CFI) and Medicare Advantage (MA) populations from 1-Oct-2018 to 31-Dec-2022, we identified adults with type 1 or type 2 diabetes (T1D/T2D) who had ≥ 1 claim for PNs and ≥ 2 claims for insulin from 1-Jan-2019 to 31-Dec-2021, with continuous medical/pharmacy eligibility for 3 months before first claim and 1 year after (follow-up). Those receiving hospice or palliative care or using mail order prescriptions were excluded. We compared actual annual fill rate of PNs with expected fill rate (assuming single use) according to prescribed insulin regimen. Whether the annual actual-to-expected ratio for PN numbers equaled 1 was evaluated using sign tests with 2-sided P values.

Results

Median annual actual-to-expected ratios ranged from 0.41 (T1D basal+prandial cohort) to 0.82 (T2D basal cohort; all P < 0.001) in the CFI population (N = 10,854), and from 0.55 (TID basal + prandial) to 1.10 (T2D basal and basal + prandial; P = 0.382-< 0.001) in the MA population (N = 32,495); medians were 0.34 and 0.55 for 4 expected T2D basal + prandial injections/day in CFI and MA populations, respectively (P < 0.001). Annual actual-to-expected ratios were < 1 for 62% and 47% of CFI and MA populations, respectively. An estimated 2%-27% and 0%-17%, respectively, depending on insulin regimen, had inadequate supplies of PNs suggesting that PNs could have been used ≥ 5 times.

Conclusion

These findings highlight the need for educating people with diabetes about reasons for avoiding PN reuse and the key role that pharmacists can play in providing this information and adequate supplies of PNs.

糖尿病投保人群的笔针使用模式:美国追溯索赔分析。
背景:使用笔式装置注射胰岛素的糖尿病患者可能会重复使用笔式针头(PN),这种做法可能会导致 PN 针尖变形、断裂和污染,并与脂肪肥厚和注射相关疼痛有关:这项回顾性研究旨在估算美国两个投保人群中糖尿病患者重复使用 PN 的程度:利用 2018 年 10 月 1 日至 2022 年 12 月 31 日期间商业全额保险(CFI)和医疗保险优势(MA)人群的索赔数据,我们确定了在 2019 年 1 月 1 日至 2021 年 12 月 31 日期间有≥1 次 PNs 索赔和≥2 次胰岛素索赔的 1 型或 2 型糖尿病(T1D/T2D)成人患者,他们在首次索赔前 3 个月和索赔后 1 年(随访)内具有连续的医疗/药房资格。接受临终关怀或姑息治疗或使用邮购处方者除外。我们根据处方胰岛素疗程比较了 PNs 的实际年填充率和预期填充率(假设一次性使用)。使用符号检验和双侧 p 值来评估 PN 数量的年度实际与预期比率是否等于 1:结果:年度实际与预期比率的中位数从 0.41(T1D 基础+餐前队列)到 0.82(T2D 基础队列;所有 pConclusions:这些发现强调了教育糖尿病患者了解避免重复使用 PN 的原因的必要性,以及药剂师在提供相关信息和充足的 PN 供应方面可以发挥的关键作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.30
自引率
14.30%
发文量
336
审稿时长
46 days
期刊介绍: The Journal of the American Pharmacists Association is the official peer-reviewed journal of the American Pharmacists Association (APhA), providing information on pharmaceutical care, drug therapy, diseases and other health issues, trends in pharmacy practice and therapeutics, informed opinion, and original research. JAPhA publishes original research, reviews, experiences, and opinion articles that link science to contemporary pharmacy practice to improve patient care.
文献相关原料
公司名称 产品信息 采购帮参考价格
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信